Correlation Between Mendus AB and Oncopeptides
Can any of the company-specific risk be diversified away by investing in both Mendus AB and Oncopeptides at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mendus AB and Oncopeptides into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mendus AB and Oncopeptides AB, you can compare the effects of market volatilities on Mendus AB and Oncopeptides and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mendus AB with a short position of Oncopeptides. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mendus AB and Oncopeptides.
Diversification Opportunities for Mendus AB and Oncopeptides
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Mendus and Oncopeptides is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Mendus AB and Oncopeptides AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncopeptides AB and Mendus AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mendus AB are associated (or correlated) with Oncopeptides. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncopeptides AB has no effect on the direction of Mendus AB i.e., Mendus AB and Oncopeptides go up and down completely randomly.
Pair Corralation between Mendus AB and Oncopeptides
Assuming the 90 days trading horizon Mendus AB is expected to under-perform the Oncopeptides. But the stock apears to be less risky and, when comparing its historical volatility, Mendus AB is 1.84 times less risky than Oncopeptides. The stock trades about -0.31 of its potential returns per unit of risk. The Oncopeptides AB is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 154.00 in Oncopeptides AB on November 7, 2024 and sell it today you would earn a total of 32.00 from holding Oncopeptides AB or generate 20.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 90.91% |
| Values | Daily Returns |
Mendus AB vs. Oncopeptides AB
Performance |
| Timeline |
| Mendus AB |
| Oncopeptides AB |
Mendus AB and Oncopeptides Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mendus AB and Oncopeptides
The main advantage of trading using opposite Mendus AB and Oncopeptides positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mendus AB position performs unexpectedly, Oncopeptides can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncopeptides will offset losses from the drop in Oncopeptides' long position.| Mendus AB vs. Cantargia AB | Mendus AB vs. BioInvent International AB | Mendus AB vs. Alligator Bioscience AB | Mendus AB vs. Oncopeptides AB |
| Oncopeptides vs. Hansa Biopharma AB | Oncopeptides vs. BioArctic AB | Oncopeptides vs. Sinch AB | Oncopeptides vs. Cantargia AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |